Home > Financial Ratios > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
Fixed Capital/Sales

    Back to All Ratios
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ADVANCED ENZYME TECHNOLOGIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.471.421.551.471.44

What is the latest Fixed Capital/Sales ratio of ADVANCED ENZYME TECHNOLOGIES ?

The latest Fixed Capital/Sales ratio of ADVANCED ENZYME TECHNOLOGIES is 1.47 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.47
Mar20241.42
Mar20231.55
Mar20221.47
Mar20211.44

How is Fixed Capital/Sales of ADVANCED ENZYME TECHNOLOGIES Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.47
3.52
Mar2024 1.42
-8.39
Mar2023 1.55
5.44
Mar2022 1.47
2.08
Mar2021 1.44 -

Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES


Compare Fixed Capital/Sales ratio of peers of ADVANCED ENZYME TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES ₹3,211.5 Cr 8.1% -8.1% -15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

8.1%

-8.1%

-15.6%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses